Browsing Tag
Massachusetts General Hospital
8 posts
Dr. Takuma Hayashi identifies LMP2 deficiency as key to uterine LMS, ushering in new era of precision cancer treatment
Dr. Takuma Hayashi’s molecular discovery of LMP2 deficiency in uterine LMS marks a breakthrough in precision oncology, unlocking new diagnostic and treatment pathways.
Groundbreaking porcine kidney transplant offers hope for end-stage kidney disease patients
In a significant medical breakthrough, biotechnology firm eGenesis has successfully transplanted a genetically engineered porcine kidney into a…
Scientists just transplanted a pig kidney into a human—and Eledon’s drug was the secret weapon
Eledon Pharmaceuticals, Inc. has announced a significant advancement in the field of xenotransplantation with the successful use of…
BrainStorm Cell Therapeutics doses patients in NurOwn phase 3 trial in ALS
NurOwn phase 3 trial : BrainStorm Cell Therapeutics, a US biotech company engaged in developing adult stem cell…
MicroMedicine to introduce new white blood cell isolation technology at SITC annual conference
MicroMedicine, a US life sciences technology company, will launch Sorterra Cell Isolation System, a white blood cell isolation…
ProTom Radiance 330 proton therapy system bags FDA 510(k) Clearance
ProTom International has been given 510(k) clearance from the US Food and Drug Administration (FDA) for its Radiance…
Novartis secures EC approval for Gilenya in pediatric multiple sclerosis treatment
Novartis has announced that the European Commission has expanded the approval of its multiple sclerosis drug, Gilenya (fingolimod),…
Pfizer’s Lorbrena receives FDA approval for advanced lung cancer treatment
Pfizer Inc., a leading US pharmaceutical company, has secured approval from the US Food and Drug Administration (FDA)…